ACTB and primary cutaneous T-cell non-Hodgkin lymphoma: [79, 80] In the Cutaneous T-Cell Lymphoma (CTCL) PDX model developed by Wu et al., the level of human plasma β-actin cfDNA correlated with tumor burden [81].